subgroup of
cancer)
→
CapableOf
→
receive androgen deprivation therapy
| Typicality: | 0.292 |
| Saliency: | 0.099 |
| at 12 months | 2 | temporal |
| prostate cancer → receive → androgen deprivation therapy | 4 |
| negative | neutral | positive |
| 0.142 | 0.794 | 0.064 |
| Raw frequency | 4 |
| Normalized frequency | 0.099 |
| Modifier score | 0.500 |
| Perplexity | 73.743 |